Gyre Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
GYRE Nasdaq 2836 www.gyretx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Gyre Therapeutics, Inc.

US High Growth Tech Stocks To Watch - May 28th, 2026 11:38 am
New Strong Sell Stocks for May 27th - May 27th, 2026 6:18 am
Gyre Therapeutics Announces NMPA Acceptance of New Drug Application for F351 (hydronidone) for CHB-Induced Liver Fibrosis Treatment - May 12th, 2026 2:05 pm
Gyre Therapeutics, Inc. (GYRE) Reports Q1 Loss, Lags Revenue Estimates - May 7th, 2026 5:45 am
Gyre Therapeutics Reports First Quarter 2026 Results and Provides Business Update - May 7th, 2026 4:00 am
Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company - May 4th, 2026 6:47 am
Exploring Three High Growth Tech Stocks In The US Market - Mar 27th, 2026 11:38 am
Gyre Therapeutics Announces China’s NMPA Grants Priority Review to the NDA for Hydronidone (F351) for CHB-Induced Liver Fibrosis Treatment - Mar 17th, 2026 5:00 am
Gyre Therapeutics, Inc. (GYRE) Q4 Earnings Miss Estimates - Mar 12th, 2026 5:10 am
Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Mar 12th, 2026 4:00 am
Voyager Therapeutics (VYGR) Reports Q4 Loss, Beats Revenue Estimates - Mar 9th, 2026 3:15 pm
Gyre Therapeutics to acquire Cullgen in $300M all-stock transaction - Mar 3rd, 2026 6:23 am
Sector Update: Health Care Stocks Retreat Late Afternoon - Mar 2nd, 2026 1:58 pm
Gyre Therapeutics Enters into Agreement to Acquire Cullgen to Gain Targeted Protein Degradation Platform and Pipeline - Mar 2nd, 2026 6:00 am
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q4 Loss, Beats Revenue Estimates - Feb 24th, 2026 5:30 pm
High Growth Tech Stocks in US for February 2026 - Feb 11th, 2026 4:38 am
Discovering Undiscovered Gems in the US Market - Jan 26th, 2026 10:33 am
High Growth Tech Stocks To Watch In The US Market January 2026 - Jan 13th, 2026 4:38 am
Gyre Therapeutics Announces Alignment with China’s CDE on Conditional Approval Pathway and Priority Review Eligibility for Hydronidone Following Pre-NDA Meeting - Jan 5th, 2026 5:00 am
Undiscovered Gems in the US Market to Explore This December 2025 - Dec 26th, 2025 4:32 am